BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20584299)

  • 1. Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.
    Ji JS; Han CW; Jang JW; Lee BI; Kim BW; Choi H; Kim JY; Kang YN; Kay CS; Choi IB
    Radiat Oncol; 2010 Jun; 5():60. PubMed ID: 20584299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer.
    Ben-Josef E; Shields AF; Vaishampayan U; Vaitkevicius V; El-Rayes BF; McDermott P; Burmeister J; Bossenberger T; Philip PA
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):454-9. PubMed ID: 15145162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
    Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study.
    Passoni P; Reni M; Cattaneo GM; Slim N; Cereda S; Balzano G; Castoldi R; Longobardi B; Bettinardi V; Gianolli L; Gusmini S; Staudacher C; Calandrino R; Di Muzio N
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1000-6. PubMed ID: 24267968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
    McIntosh A; Hagspiel KD; Al-Osaimi AM; Northup P; Caldwell S; Berg C; Angle JF; Argo C; Weiss G; Rich TA
    Cancer; 2009 Nov; 115(21):5117-25. PubMed ID: 19642177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer.
    Roxburgh P; Lumsden GR; Paul J; Harden S; Sweeting L; James A; Crellin A; Morrison R; Evans TR; McDonald AC
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):131-9. PubMed ID: 24819683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
    Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
    Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer.
    Kim HS; Yi SY; Jun HJ; Lee J; Park SH; Lee JK; Lee KT; Lee KH; Choi DW; Choi SH; Heo JS; Park YS; Lim HY; Kang WK; Park HC; Lim DH; Park JO
    Anticancer Drugs; 2010 Jan; 21(1):107-12. PubMed ID: 19829097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.
    Saif MW; Eloubeidi MA; Russo S; Steg A; Thornton J; Fiveash J; Carpenter M; Blanquicett C; Diasio RB; Johnson MR
    J Clin Oncol; 2005 Dec; 23(34):8679-87. PubMed ID: 16314628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
    Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer.
    Sun DS; Zhang JD; Li L; Dai Y; Yu JM; Shao ZY
    Br J Radiol; 2012 Mar; 85(1011):259-64. PubMed ID: 21385917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer.
    Jiang Y; Mackley HB; Kimchi ET; Zhu J; Gusani N; Kaifi J; Staveley-O'Carroll KF; Belani CP
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):205-10. PubMed ID: 24908435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.
    Morganti AG; Picardi V; Ippolito E; Massaccesi M; Macchia G; Deodato F; Mattiucci GC; Caravatta L; Di Lullo L; Giglio G; Tambaro R; Mignogna S; Caprino P; Ingrosso M; Sofo L; Cellini N; Valentini V
    Acta Oncol; 2010 May; 49(4):418-22. PubMed ID: 20397772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
    Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
    Saif MW; Black G; Johnson M; Russo S; Diasio R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):771-5. PubMed ID: 16552574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.
    Rakhra S; Strauss JB; Robertson J; McGinn CJ; Kim T; Huang J; Blake A; Helenowski I; Hayes JP; Mulcahy M; Small W
    J Gastrointest Cancer; 2016 Jun; 47(2):196-201. PubMed ID: 27112332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancer.
    Huang MY; Chen CF; Huang CM; Tsai HL; Yeh YS; Ma CJ; Wu CH; Lu CY; Chai CY; Huang CJ; Wang JY
    Biomed Res Int; 2014; 2014():352083. PubMed ID: 24949438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
    Crane CH; Ellis LM; Abbruzzese JL; Amos C; Xiong HQ; Ho L; Evans DB; Tamm EP; Ng C; Pisters PW; Charnsangavej C; Delclos ME; O'Reilly M; Lee JE; Wolff RA
    J Clin Oncol; 2006 Mar; 24(7):1145-51. PubMed ID: 16505434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
    Wilkowski R; Thoma M; Weingandt H; Dühmke E; Heinemann V
    JOP; 2005 May; 6(3):216-30. PubMed ID: 15883472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.